Efficacy of citrulline supplementation to decrease the risk of pulmonary hypertension after congenital heart disease surgery. A local experience.
Pulmonary hypertension (PH) is a major cause of morbi-mortality among patients with congenital heart disease (CHD) and also a potentially severe complication after surgical repair. Oral citrulline, a precursor to NO synthesis, is safe and efficacious for decreasing the risk of postoperative PH. O...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad Nacional de Córdoba
2020-12-01
|
Series: | Revista de la Facultad de Ciencias Médicas de Córdoba |
Subjects: | |
Online Access: | https://revistas.unc.edu.ar/index.php/med/article/view/27936 |